NASDAQ
11.35USD
-0.70 (-5.81%)
We have scored 3 news catalysts on Korro Bio, Inc. (KRRO) over the past 12 months. The biggest single-day move next to one of them came Oct 23, 2026, when KRRO closed −3.3%: “Korro Bio, Inc. (KRRO) Surges 29.7%: Is This an Indication of Further Gains?”. Coverage across the window leans positive (average ticker sentiment +0.47). Most of the impact sits in sector healthcare and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
170.4M
P/E
—
EPS
—
Beta
2.36
52W range
5.2-42.7
Day range
11.28–12.04
Open
12.04
Prev close
12.05
Volume
71.6K
Avg volume
190.2K
Dividend
0.00
IPO
2019-10-03
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Korro Bio, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for KRRO: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
